https://m2.mtmt.hu/ hun 2026-06-27 19:22 JournalArticle 30731425 VALIDATED true 0 false 2026-06-01T16:29:01.874+0000 2022-05-11T08:11:23.616+0000 2019-07-05T13:49:32.974+0000 true 10014641 Kökény Gábor /api/author/10014641 Author Kökény Gábor (Nefrológia) true 10014641 2022-07-20T11:08:48.753+0000 2020-01-20T08:58:32.125+0000 true 10069606 Pintér Ibolya Katalin /api/admin/10069606 Admin Pintér Ibolya Katalin (SE_AOK_TranszlációsMedInt_Admin5_PI, admin) true 2022-05-11T08:11:23.818+0000 true 10062062 Gere Tamásné /api/admin/10062062 Admin Gere Tamásné (SE_KK_Admin5_GT, admin) true 10062062 true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Szakcikk (Folyóiratcikk) 101 true 10000059 true 1 /api/category/1 Category Tudományos true 1 Németh, Ágnes true true /api/journal/10015510 REVIEWED BMC NEPHROLOGY 1471-2369 1471-2369 true false 10015510 false 10015510 true 1471-2369 1471-2369 Journal FOREIGN 20 1 245 245 9 2019 BackgroundIt has been proposed that peroxisome proliferator-activated receptor-gamma (PPAR gamma) agonists might reduce renal fibrosis, however, several studies had contradictory results. Moreover, the possible interaction of TGF-beta(1), PPAR gamma, and transcription factors in renal fibrosis have not been investigated. We hypothesized that oral pioglitazone treatment would inhibit TGF-beta-driven renal fibrosis and its progression, by modulating profibrotic transcription factors in TGF-beta(1) transgenic mice.MethodsMale C57Bl/6J mice (control, CTL, n=14) and TGF-beta overexpressing transgenic mice (TGF beta, n=14, having elevated plasma TGF-beta(1) level) were divided in two sets at 10weeks of age. Mice in the first set were fed with regular rodent chow (CTL and TGF beta, n=7/group). Mice in the second set were fed with chow containing pioglitazone (at a dose of 20mg/kg/day, CTL+Pio and TGF beta+Pio, n=7/group). After 5weeks of treatment, blood pressure was assessed and urine samples were collected, and the kidneys were analyzed for histology, mRNA and protein expression.ResultsTGF-beta(1) induced glomerulosclerosis and tubulointerstitial damage were significantly reduced by pioglitazone. Pioglitazone inhibited renal mRNA expression of all the profibrotic effectors: type-III collagen, TGF-beta(1), CTGF and TIMP-1, and alike transcription factors cFos/cJun and protein expression of EGR-1, and STAT3 protein phosphorylation.ConclusionsOral administration of PPAR gamma agonist pioglitazone significantly reduces TGF-beta(1)-driven renal fibrosis, via the attenuation of EGR-1, STAT3 and AP-1. This implies that PPAR gamma agonists might be effective in the treatment of chronic kidney disease patients. true true 2019 true true true false true false GOLD 2026-06-01 true https://doi.org/10.1186/s12882-019-1431-x 69 0 69 59 9 69 68 64 61 68 68 58 58 59 10 0 69 59 69 59 0 5 5 Folyóiratcikk Journal Article 24 69 Könyvrészlet Chapter in Book 25 0 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2020 0 10 9 10 9 2021 0 10 9 10 9 2022 0 12 10 12 10 2023 0 13 10 13 10 2024 0 15 13 15 13 2025 0 8 7 8 7 2026 0 1 1 1 1 Q2 true 10015693,10014641 false false false 2019-10-14T10:18:24.838+0000 Kórélettani Intézet (SE / AOK / I) 3 9 1 5 0 true Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 87511315 /api/authorship/87511315 Németh, Ágnes [Németh, Ágnes (Nephrológia), szerző] Kórélettani Intézet (SE / AOK / I) 1 0.2 true false Author 10051754 /api/author/10051754 Németh Ágnes (Nephrológia) Németh Ágnes true 10051754 true Németh Ágnes true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 87511316 /api/authorship/87511316 Mózes, Miklós M. [Mózes, Miklós (Nephrologia), szerző] Kórélettani Intézet (SE / AOK / I) 2 0.2 false false Author 10015693 /api/author/10015693 Mózes Miklós (Nephrologia) Mózes Miklós true 10015693 true Mózes Miklós M. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 87511317 /api/authorship/87511317 Calvier, Laurent 3 0.2 false false Calvier Laurent true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 87511318 /api/authorship/87511318 Hansmann, Georg 4 0.2 false false Hansmann Georg true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 87511319 /api/authorship/87511319 Kökény, Gábor ✉ [Kökény, Gábor (Nefrológia), szerző] Kórélettani Intézet (SE / AOK / I) 5 0.2 false true true Author 10014641 /api/author/10014641 Kökény Gábor (Nefrológia) Kökény Gábor true 10014641 true Kökény Gábor true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 16053616 /api/publicationidentifier/16053616 DOI: 10.1186/s12882-019-1431-x PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true GOLD true IDENTICAL 10.1186/s12882-019-1431-x https://doi.org/10.1186/s12882-019-1431-x false true PublicationIdentifier 16053615 /api/publicationidentifier/16053615 WoS: 000474559900001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 000474559900001 https://www.webofscience.com/wos/woscc/full-record/000474559900001 false true PublicationIdentifier 16517777 /api/publicationidentifier/16517777 Scopus: 85069269365 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85069269365 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85069269365 false true PublicationIdentifier 15807355 /api/publicationidentifier/15807355 PubMed: 31277592 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 31277592 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=31277592&dopt=Abstract false true SjrRating 10860690 /api/sjrrating/10860690 sjr:Q2 (2019) Scopus - Nephrology BMC NEPHROLOGY 1471-2369 22 0.49 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 2727 /api/classificationexternal/2727 Scopus - Nephrology true 2727 true Q2 DIRECT true true Reference 2501121 /api/reference/2501121 1. Kazancioglu R. Risk factors for chronic kidney disease: an update. Kidney Int Suppl (2011). 2013 1 false true Reference 2501122 /api/reference/2501122 2. 3:368–71., DOI: 10.1038/kisup.2013.79 2 10.1038/kisup.2013.79 false true Reference 2501123 /api/reference/2501123 3. Massague J. TGF-beta signal transduction. Annu Rev Biochem. 1998 3 false true Reference 2501124 /api/reference/2501124 4. 67:753–91., DOI: 10.1146/annurev.biochem.67.1.753 4 10.1146/annurev.biochem.67.1.753 false true Reference 2501125 /api/reference/2501125 5. Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J. 2004 5 false true Reference 2501126 /api/reference/2501126 6. 18:816–27., DOI: 10.1096/fj.03-1273rev 6 10.1096/fj.03-1273rev false true Reference 2501127 /api/reference/2501127 7. Karin M, Liu Z, Zandi E. AP-1 function and regulation. Curr Opin Cell Biol. 1997 7 false true Reference 2501128 /api/reference/2501128 8. 9:240–6., DOI: 10.1016/S0955-0674(97)80068-3 8 10.1016/S0955-0674(97)80068-3 false true Reference 2501129 /api/reference/2501129 9. Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, Wakefield L, Roberts AB, Sporn MB, Thorgeirsson SS. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci U S A. 1995 9 false true Reference 2501130 /api/reference/2501130 10. 92:2572–6., DOI: 10.1073/pnas.92.7.2572 10 10.1073/pnas.92.7.2572 false true Reference 2501131 /api/reference/2501131 11. Mozes MM, Szoleczky P, Rosivall L, Kokeny G. Sustained hyperosmolarity increses TGF-ss1 and Egr-1 expression in the rat renal medulla. BMC Nephrol. 2017 11 false true Reference 2501132 /api/reference/2501132 12. 18:209., DOI: 10.1186/s12882-017-0626-2 12 10.1186/s12882-017-0626-2 false true Reference 2501133 /api/reference/2501133 13. Bhattacharyya S, Fang F, Tourtellotte W, Varga J. Egr-1: new conductor for the tissue repair orchestra directs harmony (regeneration) or cacophony (fibrosis). J Pathol. 2013 13 false true Reference 2501134 /api/reference/2501134 14. 229:286–97., DOI: 10.1002/path.4131 14 10.1002/path.4131 false true Reference 2501135 /api/reference/2501135 15. Marrero MB, Banes-Berceli AK, Stern DM, Eaton DC. Role of the JAK/STAT signaling pathway in diabetic nephropathy. Am J Physiol Renal Physiol. 2006 15 false true Reference 2501136 /api/reference/2501136 16. 290:F762–8., DOI: 10.1152/ajprenal.00181.2005 16 10.1152/ajprenal.00181.2005 false true Reference 2501137 /api/reference/2501137 17. Martinez-Lostao L, Ordi-Ros J, Balada E, Segarra-Medrano A, Majo-Masferrer J, Labrador-Horrillo M, Vilardell-Tarres M. Activation of the signal transducer and activator of transcription-1 in diffuse proliferative lupus nephritis. Lupus. 2007 17 false true Reference 2501138 /api/reference/2501138 18. 16:483–8., DOI: 10.1177/0961203307079618 18 10.1177/0961203307079618 false true Reference 2501139 /api/reference/2501139 19. Matsui F, Meldrum KK. The role of the Janus kinase family/signal transducer and activator of transcription signaling pathway in fibrotic renal disease. J Surg Res. 2012 19 false true Reference 2501140 /api/reference/2501140 20. 178:339–45., DOI: 10.1016/j.jss.2012.06.050 20 10.1016/j.jss.2012.06.050 false true Reference 2501141 /api/reference/2501141 21. Kalechman Y, Gafter U, Weinstein T, Chagnac A, Freidkin I, Tobar A, Albeck M, Sredni B. Inhibition of interleukin-10 by the immunomodulator AS101 reduces mesangial cell proliferation in experimental mesangioproliferative glomerulonephritis: association with dephosphorylation of STAT3. J Biol Chem. 2004 21 false true Reference 2501142 /api/reference/2501142 22. 279:24724–32., DOI: 10.1074/jbc.M312006200 22 10.1074/jbc.M312006200 false true Reference 2501143 /api/reference/2501143 23. Huang JS, Guh JY, Hung WC, Yang ML, Lai YH, Chen HC, Chuang LY. Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells. Biochem J. 1999 23 false true Reference 2501144 /api/reference/2501144 24. 342(Pt 1):231–8., DOI: 10.1042/bj3420231 24 10.1042/bj3420231 false true Reference 2501145 /api/reference/2501145 25. Nakajima H, Takenaka M, Kaimori JY, Hamano T, Iwatani H, Sugaya T, Ito T, Hori M, Imai E. Activation of the signal transducer and activator of transcription signaling pathway in renal proximal tubular cells by albumin. J Am Soc Nephrol. 2004 25 false true Reference 2501146 /api/reference/2501146 26. 15:276–85., DOI: 10.1097/01.ASN.0000109672.83594.02 26 10.1097/01.ASN.0000109672.83594.02 false true Reference 2501147 /api/reference/2501147 27. Ogata H, Chinen T, Yoshida T, Kinjyo I, Takaesu G, Shiraishi H, Iida M, Kobayashi T, Yoshimura A. Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production. Oncogene. 2006 27 false true Reference 2501148 /api/reference/2501148 28. 25:2520–30., DOI: 10.1038/sj.onc.1209281 28 10.1038/sj.onc.1209281 false true Reference 2501149 /api/reference/2501149 29. Kuratsune M, Masaki T, Hirai T, Kiribayashi K, Yokoyama Y, Arakawa T, Yorioka N, Kohno N. Signal transducer and activator of transcription 3 involvement in the development of renal interstitial fibrosis after unilateral ureteral obstruction. Nephrology (Carlton). 2007 29 false true Reference 2501150 /api/reference/2501150 30. 12:565–71., DOI: 10.1111/j.1440-1797.2007.00881.x 30 10.1111/j.1440-1797.2007.00881.x false true Reference 2501151 /api/reference/2501151 31. Calvier L, Chouvarine P, Legchenko E, Hoffmann N, Geldner J, Borchert P, Jonigk D, Mozes MM, Hansmann G. PPARgamma links BMP2 and TGFbeta1 pathways in vascular smooth muscle cells, regulating cell proliferation and glucose metabolism. Cell Metab. 2017 31 false true Reference 2501152 /api/reference/2501152 32. 25:1118–1134 e1117., DOI: 10.1016/j.cmet.2017.03.011 32 10.1016/j.cmet.2017.03.011 false true Reference 2501153 /api/reference/2501153 33. Chiarelli F, Di Marzio D. Peroxisome proliferator-activated receptor-gamma agonists and diabetes: current evidence and future perspectives. Vasc Health Risk Manag. 2008 33 false true Reference 2501154 /api/reference/2501154 34. 4:297–304., DOI: 10.2147/VHRM.S993 34 10.2147/VHRM.S993 false true Reference 2501155 /api/reference/2501155 35. Kernan WN, Viscoli CM, Furie KL, Young LH, Inzucchi SE, Gorman M, Guarino PD, Lovejoy AM, Peduzzi PN, Conwit R, et al. Pioglitazone after ischemic stroke or transient ischemic attack. N Engl J Med. 2016 35 false true Reference 2501156 /api/reference/2501156 36. 374:1321–31., DOI: 10.1056/NEJMoa1506930 36 10.1056/NEJMoa1506930 false true Reference 2501157 /api/reference/2501157 37. Wang W, Liu F, Chen N. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists attenuate the profibrotic response induced by TGF-beta1 in renal interstitial fibroblasts. Mediat Inflamm. 2007 37 false true Reference 2501158 /api/reference/2501158 38. 2007:62641. 38 false true Reference 2501159 /api/reference/2501159 39. Kawai T, Masaki T, Doi S, Arakawa T, Yokoyama Y, Doi T, Kohno N, Yorioka N. PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta. Lab Investig. 2009 39 false true Reference 2501160 /api/reference/2501160 40. 89:47–58., DOI: 10.1038/labinvest.2008.104 40 10.1038/labinvest.2008.104 false true Reference 2501161 /api/reference/2501161 41. Zhang Y, Wang J, Zhou QD, Zhang CH, Li Q, Huang S, Zhan J, Wang K, Liu YY, Xu G. Peroxisome proliferator-activated receptor-gamma agonist pioglitazone fails to attenuate renal fibrosis caused by unilateral ureteral obstruction in mice. J Huazhong Univ Sci Technolog Med Sci. 2016 41 false true Reference 2501162 /api/reference/2501162 42. 36:41–7., DOI: 10.1007/s11596-016-1539-1 42 10.1007/s11596-016-1539-1 false true Reference 2501163 /api/reference/2501163 43. Kopp JB, Factor VM, Mozes M, Nagy P, Sanderson N, Bottinger EP, Klotman PE, Thorgeirsson SS. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Investig. 1996 43 false true Reference 2501164 /api/reference/2501164 44. 74:991–1003. 44 false true Reference 2501165 /api/reference/2501165 45. Czirok S, Fang L, Radovits T, Szabo G, Szenasi G, Rosivall L, Merkely B, Kokeny G. Cinaciguat ameliorates glomerular damage by reducing ERK1/2 activity and TGF-ss expression in type-1 diabetic rats. Sci Rep. 2017 45 false true Reference 2501166 /api/reference/2501166 46. 7:11218., DOI: 10.1038/s41598-017-10125-3 46 10.1038/s41598-017-10125-3 false true Reference 2501167 /api/reference/2501167 47. Curtis MJ, Alexander S, Cirino G, Docherty JR, George CH, Giembycz MA, Hoyer D, Insel PA, Izzo AA, Ji Y, et al. Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers. Br J Pharmacol. 2018 47 false true Reference 2501168 /api/reference/2501168 48. 175:987–93., DOI: 10.1111/bph.14153 48 10.1111/bph.14153 false true Reference 2501169 /api/reference/2501169 49. Viau A, El Karoui K, Laouari D, Burtin M, Nguyen C, Mori K, Pillebout E, Berger T, Mak TW, Knebelmann B, et al. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. J Clin Invest. 2010 49 false true Reference 2501170 /api/reference/2501170 50. 120:4065–76., DOI: 10.1172/JCI42004 50 10.1172/JCI42004 false true Reference 2501171 /api/reference/2501171 51. Soccio RE, Chen ER, Lazar MA. Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes. Cell Metab. 2014 51 false true Reference 2501172 /api/reference/2501172 52. 20:573–91., DOI: 10.1016/j.cmet.2014.08.005 52 10.1016/j.cmet.2014.08.005 false true Reference 2501173 /api/reference/2501173 53. Yang J, Zhou Y, Guan Y. PPARgamma as a therapeutic target in diabetic nephropathy and other renal diseases. Curr Opin Nephrol Hypertens. 2012 53 false true Reference 2501174 /api/reference/2501174 54. 21:97–105., DOI: 10.1097/MNH.0b013e32834de526 54 10.1097/MNH.0b013e32834de526 false true Reference 2501175 /api/reference/2501175 55. Hansmann G, Wagner RA, Schellong S, Perez VA, Urashima T, Wang L, Sheikh AY, Suen RS, Stewart DJ, Rabinovitch M. Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation. Circulation. 2007 55 false true Reference 2501176 /api/reference/2501176 56. 115:1275–84., DOI: 10.1161/CIRCULATIONAHA.106.663120 56 10.1161/CIRCULATIONAHA.106.663120 false true Reference 2501177 /api/reference/2501177 57. McDonald JA. Extracellular matrix assembly. Annu Rev Cell Biol. 1988 57 false true Reference 2501178 /api/reference/2501178 58. 4:183–207., DOI: 10.1146/annurev.cb.04.110188.001151 58 10.1146/annurev.cb.04.110188.001151 false true Reference 2501179 /api/reference/2501179 59. Shoulders MD, Raines RT. Collagen structure and stability. Annu Rev Biochem. 2009 59 false true Reference 2501180 /api/reference/2501180 60. 78:929–58., DOI: 10.1146/annurev.biochem.77.032207.120833 60 10.1146/annurev.biochem.77.032207.120833 false true Reference 2501181 /api/reference/2501181 61. Yoshioka K, Takemura T, Murakami K, Okada M, Hino S, Miyamoto H, Maki S. Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Investig. 1993 61 false true Reference 2501182 /api/reference/2501182 62. 68:154–63. 62 false true Reference 2501183 /api/reference/2501183 63. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int. 2006 63 false true Reference 2501184 /api/reference/2501184 64. 69:213–7., DOI: 10.1038/sj.ki.5000054 64 10.1038/sj.ki.5000054 false true Reference 2501185 /api/reference/2501185 65. Ma LJ, Marcantoni C, Linton MF, Fazio S, Fogo AB. Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats. Kidney Int. 2001 65 false true Reference 2501186 /api/reference/2501186 66. 59:1899–910., DOI: 10.1046/j.1523-1755.2001.0590051899.x 66 10.1046/j.1523-1755.2001.0590051899.x false true Reference 2501187 /api/reference/2501187 67. Benigni A, Zoja C, Tomasoni S, Campana M, Corna D, Zanchi C, Gagliardini E, Garofano E, Rottoli D, Ito T, et al. Transcriptional regulation of nephrin gene by peroxisome proliferator-activated receptor-gamma agonist: molecular mechanism of the antiproteinuric effect of pioglitazone. J Am Soc Nephrol. 2006 67 false true Reference 2501188 /api/reference/2501188 68. 17:1624–32., DOI: 10.1681/ASN.2005090983 68 10.1681/ASN.2005090983 false true Reference 2501189 /api/reference/2501189 69. Sivarajah A, Chatterjee PK, Patel NS, Todorovic Z, Hattori Y, Brown PA, Stewart KN, Mota-Filipe H, Cuzzocrea S, Thiemermann C. Agonists of peroxisome-proliferator activated receptor-gamma reduce renal ischemia/reperfusion injury. Am J Nephrol. 2003 69 false true Reference 2501190 /api/reference/2501190 70. 23:267–76., DOI: 10.1159/000072088 70 10.1159/000072088 false true Reference 2501191 /api/reference/2501191 71. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008 71 false true Reference 2501192 /api/reference/2501192 72. 214:199–210., DOI: 10.1002/path.2277 72 10.1002/path.2277 false true Reference 2501193 /api/reference/2501193 73. Roberts AB, McCune BK, Sporn MB. TGF-beta: regulation of extracellular matrix. Kidney Int. 1992 73 false true Reference 2501194 /api/reference/2501194 74. 41:557–9., DOI: 10.1038/ki.1992.81 74 10.1038/ki.1992.81 false true Reference 2501195 /api/reference/2501195 75. Wu M, Melichian DS, Chang E, Warner-Blankenship M, Ghosh AK, Varga J. Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma. Am J Pathol. 2009 75 false true Reference 2501196 /api/reference/2501196 76. 174:519–33., DOI: 10.2353/ajpath.2009.080574 76 10.2353/ajpath.2009.080574 false true Reference 2501197 /api/reference/2501197 77. Liang Y, Jin Y, Li Y. Expression of JAKs/STATs pathway molecules in rat model of rapid focal segmental glomerulosclerosis. Pediatr Nephrol. 2009 77 false true Reference 2501198 /api/reference/2501198 78. 24:1661–71., DOI: 10.1007/s00467-009-1163-4 78 10.1007/s00467-009-1163-4 false true Reference 2501199 /api/reference/2501199 79. Pang M, Ma L, Gong R, Tolbert E, Mao H, Ponnusamy M, Chin YE, Yan H, Dworkin LD, Zhuang S. A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy. Kidney Int. 2010 79 false true Reference 2501200 /api/reference/2501200 80. 78:257–68., DOI: 10.1038/ki.2010.154 80 10.1038/ki.2010.154 false true /api/publication/30731425 Németh Ágnes et al. The PPAR gamma agonist pioglitazone prevents TGF-beta induced renal fibrosis by repressing EGR-1 and STAT3. (2019) BMC NEPHROLOGY 1471-2369 1471-2369 20 1<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10051754"><a href="/gui2/?type=authors&mode=browse&sel=10051754" target="_blank">Németh Ágnes (<span class="authorship-author-name">Németh Ágnes</span> <span class="authorAux-mtmt"> Nephrológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Kórélettani Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10015693"><a href="/gui2/?type=authors&mode=browse&sel=10015693" target="_blank">Mózes Miklós M. (<span class="authorship-author-name">Mózes Miklós</span> <span class="authorAux-mtmt"> Nephrologia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Kórélettani Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Calvier Laurent </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Hansmann Georg </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10014641"><a href="/gui2/?type=authors&mode=browse&sel=10014641" target="_blank">Kökény Gábor ✉ (<span class="authorship-author-name">Kökény Gábor</span> <span class="authorAux-mtmt"> Nefrológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Kórélettani Intézet</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;30731425" target="_blank">The PPAR gamma agonist pioglitazone prevents TGF-beta induced renal fibrosis by repressing EGR-1 and STAT3</a></div> <div> <span class="journal-title">BMC NEPHROLOGY</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/1471-2369">1471-2369</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1471-2369">1471-2369</a>)</span>: <span class="journal-volume">20</span> <span class="journal-issue">1</span> <span class="page"> Paper 245. 9 p. </span> <span class="year">(2019)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_GOLD" title=" Gold "> <a style="color:blue" title="10.1186/s12882-019-1431-x" target="_blank" href="https://doi.org/10.1186/s12882-019-1431-x"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="000474559900001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/000474559900001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85069269365" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85069269365"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="31277592" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=31277592&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Nephrology&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q2</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 69</span> | Független: 59 | Függő: 10 | Nem jelölt: 0 | WoS jelölt: 64 | Scopus jelölt:&nbsp;61 | WoS/Scopus jelölt:&nbsp;68 | DOI jelölt:&nbsp;68 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;30731425&sort=publishedYear,desc&sort=title"> Idézett közlemények száma: 5 </a> </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 30731425</span> | <span class="status-data status-VALIDATED"> Egyeztetett </span> Forrás Idéző | <span class="type-subtype">Folyóiratcikk ( Szakcikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="lastModified">Utolsó módosítás: 2022.05.11. 10:11 Gere Tamásné (SE_KK_Admin5_GT, admin) </div> </div></div>